--- title: "NBRVF.US (NBRVF.US) — 相关新闻" type: "Symbol" locale: "zh-CN" url: "https://longbridge.com/zh-CN/quote/NBRVF.US/news.md" symbol: "NBRVF.US" name: "NBRVF.US" parent: "https://longbridge.com/zh-CN/quote/NBRVF.US.md" datetime: "2026-03-17T13:31:54.880Z" locales: - [en](https://longbridge.com/en/quote/NBRVF.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/NBRVF.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/NBRVF.US/news.md) --- > 支持的语言: [English](https://longbridge.com/en/quote/NBRVF.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/NBRVF.US/news.md) # NBRVF.US (NBRVF.US) — 相关新闻 ### [REG - AIM - AIM Notice - 26/02/2026](https://longbridge.com/zh-CN/news/277002244.md) *2026-02-26T08:00:00.000Z* > The London Stock Exchange has admitted the following securities to trading on AIM as of February 26, 2026: Allergy Thera ### [Keenova Unveils Clinical Data from Phase 2 Plantar Fibromatosis Study at the ACFAS Annual Meeting | MNK Stock News](https://longbridge.com/zh-CN/news/276735558.md) *2026-02-24T04:30:00.000Z* > Keenova Therapeutics plc presented clinical data on collagenase clostridium histolyticum (CCH) for plantar fibromatosis ### [Keenova's new manuscript on plantar fibromatosis treatment patterns in foot surgery journal highlights mostly conservative treatments for the rare condition, emphasizing need for long-term outcome research.](https://longbridge.com/zh-CN/news/276057782.md) *2026-02-16T12:33:44.000Z* > Plantar fibromatosis, a rare condition affecting a small number of individuals, typically prompts newly diagnosed patien ### [07:30 ETKeenova Announces New Manuscript on Plantar Fibromatosis Treatment Patterns in Peer-Reviewed Journal of Foot and Ankle Surgery](https://longbridge.com/zh-CN/news/276056886.md) *2026-02-16T12:32:20.000Z* > Keenova Therapeutics plc has published a manuscript in The Journal of Foot and Ankle Surgery detailing real-world treatm ### [Nabriva Therapeutics ( NASDAQ:NBRV ) Coverage Initiated by Analysts at StockNews.com](https://longbridge.com/zh-CN/news/208869262.md) *2024-07-15T10:21:36.000Z* > StockNews.com started coverage on shares of Nabriva Therapeutics ( NASDAQ:NBRV - Free Report ) in a report issued on Sun ### [Nabriva Therapeutics ( NASDAQ:NBRV ) Now Covered by Analysts at StockNews.com](https://longbridge.com/zh-CN/news/208789773.md) *2024-07-14T05:36:33.000Z* > StockNews.com initiated coverage on shares of Nabriva Therapeutics ( NASDAQ:NBRV - Get Free Report ) in a research repor